|
|
Current position:
Head of Department, Department of Pathology, National University of Singapore
Past employment history:
1998 - 2005 Associate Professor, Department of Pathology, NUS
1990 - 1998 Senior Lecturer, Department of Pathology, NUS
1987 - 1990 Lecturer (Scale A) Department of Pathology, NUS
1992 - 1987 Senior Tutor, Department of Pathology, NUS
1981 – 1982 House Officer, Ministry of Health
Academic qualifications:
BA (magna cum laude) (1974 - 1977) Yale University, USA
MD (1977 – 1981) Johns Hopkins University, USA
MRCPath (1987) United Kingdom
FRCPath (1997) United Kingdom
MRCPath (1997) United Kingdom
Selected publications:
1. Shim, Winston S. N, M. Teh, P. Mack and R. Ge. Inhibition Of Angiopoietin-1 Expression In Tumor Cells By An Antisense RNA Approach Inhibited Xenograft Tumor Growth In Immunodeficient Mice. International Journal of Cancer, Vol 94, 6-15, 2001.
2. Shim, W. S. N, M. Teh, A. Bapna, I, Kim, G-Y Koh, P. Mack and R. Ge. Angiopoietin-1 Promotes Tumor Angiogenesis and Tumor Vessel Plasticity of Human Cervical Cancer in Mice. Experimental Cell Research, Vol 279, 299-309, 2002.
3. Teh, M, K B Tan, B L Seet and K G Yeoh. A study of p53 immunostaining in the gastric epithelium of cagA positive and cagA negative helicobacter pylori gastritis. Cancer, 95, 3 (2002): 499-505. (United States).
4. Yin, Y, J Que, M Teh, W P Cao, R M Oakley EL and S K Lim. Embryonic cell lines with endothelial potential: an in vitro system for studying endothelial differentiation. Arteriosclerosis Thrombosis and Vascular Biology, 4 (24 April 2004): 691-696. (United States).
5. Putti, T C, M Teh and Y S Lee, Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX2 as potential markers. Modern Pathology, 17, 4 (April 2004): 468-475.
Current and previous support from A*STAR or other sources (partial list):
As collaborator
Development of angiogenic peptides for therapeutic applications and characterization of their modes of action; BMRC 2002 - ; Approx. $850,000.00
Transplantation of tissue stem cells from adult bone marrow for tissue replacement and genetic therapy: an in vivo cellular alternative to bioengineering and vector-mediated gene therapy; BMRC 2002 - ; Approx. $1.5 million
Auto transplantation of mesenchymal stem cell into chronically failing heart-porcine model; NMRC; 2002 - 2005; Approx. $168,000.00
Crossing the histocompatibility barriers using transient immunosuppression: Implications in the cellular cardiomyoplasty using human skeletal myoblasts for cardiac repair; NMRC; 2002 - 2005; Approx. $175,000.00
SCS Grant – Establishment of a gastric cancer epidemiology, clinical and genetics programme (GCEP) for population-based studies to identify clinical, serologic, pathologic and genetic markers which can be used to define an optimal approach to gastric cancer screening.
|
|
